(EMAILWIRE.COM, November 13, 2019 ) Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the Veterinary Pain Management Market. However, increasing pet care costs may be a key restraining factor for the market in the next five years.

Based on product, the market has been segmented into drugs and devices. The veterinary pain management drugs market is further segmented on the basis of type of drugs and route of drug administration. The veterinary pain management devices market is further segmented into laser therapy devices and electromagnetic therapy devices.

The drugs segment accounted for the largest share of the market in 2017. The large share of this product segment is mainly attributed to the fact that drugs are more affordable, easier to administer, and treat a wider range of diseases that cause pain in both farm and companion animals.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96167677

By application, the veterinary pain management market has been segmented into joint pain, postoperative pain, cancer, and other applications. Other applications include traumatic pain, abdominal pain, neuropathic pain, dermatological pain, and mastitis. Joint pain held the largest share of the global market in 2017 due to the growing pet population, rising prevalence of osteoarthritis and musculoskeletal disorders, and increasing population of obese and overweight pets.

By animal type, the global market is segmented into companion and livestock animals. The companion animal segment accounted for the largest share of the global market. The large share of this segment can primarily be attributed to increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure.

Based on distribution channel, the veterinary pain management market is segmented into hospitals & clinics and pharmacy. Veterinary hospitals & clinics accounted for a larger market share primarily due to factors such as the increasing number of veterinary clinics and hospitals, growing ownership of companion animals, and increasing veterinary expenditure.

Global veterinary pain management market has been studied for North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in veterinary pain management market, primarily due to the significant growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China.

The prominent players in the veterinary pain management market are Zoetis (US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=96167677

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com